Kind Pharmaceuticals
PrivateLast Round
Series C
Nov 12, 2025
Total Funding Raised
$144M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kind Pharmaceuticals operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series C round in November 2025.
Kind Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of innovative therapeutics for hematological diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kind Pharmaceuticals Comparables
Compare Kind Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kyntra Bio, Inc. | 75% | |
| Akebia Therapeutics, Inc. | 72% | |
| GSK plc | 71% |
For institutional investors. Book with your work email.
Kind Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 12, 2025 | ||||
| Series B | Oct 1, 2021 | ||||
| Series A | Oct 1, 2019 |
For institutional investors. Book with your work email.
Kind Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Light Venture Capital | Series C, Series B |
| Grand Investment | Series C |
| Efung Capital | Series B, Series C |
| Decheng Capital | Series B, Series A |
| Gaorong Capital | Series C, Series B |
| 建发新兴投资 | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 229% MoM.
- Nov 12, 2025
$59M round led by China Grand Enterprises, Inc.
For institutional investors. Book with your work email.
Kind Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kind Pharmaceuticals's valuation, stock price, and market status.
Is Kind Pharmaceuticals a public or private company?
Kind Pharmaceuticals is a private company.
What is the current stock price of Kind Pharmaceuticals?
Kind Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Kind Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kind Pharmaceuticals worth (valuation)?
Valuation information for Kind Pharmaceuticals is not publicly available.
Can I buy Kind Pharmaceuticals stock?
Kind Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kind Pharmaceuticals's last funding round?
Kind Pharmaceuticals's most recent funding round was Series C on November 12, 2025.
Who are the main investors in Kind Pharmaceuticals?
Key investors in Kind Pharmaceuticals include Northern Light Venture Capital, Grand Investment, Decheng Capital, Gaorong Capital, 建发新兴投资.
Will Kind Pharmaceuticals IPO soon?
No public IPO plans have been announced for Kind Pharmaceuticals.
How can I track Kind Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Kind Pharmaceuticals's shares on secondary markets.